Efgartigimod Efficacy and Safety in CIDP - ADHERE and ADHERE+ Trials
Efgartigimod Efficacy and Safety in CIDP - ADHERE and ADHERE+ Trials #Neurology #CIDP #Efgartigimod
2 Touko 202510min
Telitacicept Shows Strong Efficacy for Generalized Myasthenia Gravis
Telitacicept Shows Strong Efficacy for Generalized Myasthenia Gravis
27 Huhti 20257min
C5 vs FcRn inhibitors for generalized myasthenia gravis
Comparison of C5 vs FcRn inhibitors for generalized myasthenia gravis #Neurology #Myasthenia
27 Huhti 20257min
MMF for anti-NMDA antibody maintenance
MMF for anti-NMDA antibody maintenance #Neurology
27 Huhti 20259min
European Guidelines for Assessment and Management of Neurogenic Bladder
This document presents new guidelines, called NEUROGED, developed by European and international neurological and urological societies to aid practicing neurologists in the assessment and management of...
20 Huhti 202515min
ADVANCE CIDP -IVIG Clinical Trial
This research article from the European Journal of Neurology presents the results of the ADVANCE-CIDP IVIG trial, which investigated the effectiveness and safety of intravenous immunoglobulin 10% ther...
20 Huhti 20257min
Multifocal Motor Neuropathy - A Comprehensive Review
Multifocal Motor Neuropathy - A Comprehensive Review
12 Huhti 202525min
Bone marrow transplantation for MS, ECTRIMS Recommendation
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
12 Huhti 202513min
